Page last updated: 2024-08-24

darglitazone and cl 316243

darglitazone has been researched along with cl 316243 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bakopanos, E; Silva, JE	1

Other Studies

1 other study(ies) available for darglitazone and cl 316243

Article	Year
Thiazolidinediones inhibit the expression of beta3-adrenergic receptors at a transcriptional level. Diabetes, 2000, Volume: 49, Issue:12 Topics: 3T3 Cells; Adrenergic beta-Agonists; Animals; Carrier Proteins; Cell Line; Chromans; Dioxoles; Drug Combinations; Half-Life; Ion Channels; Membrane Proteins; Mice; Mitochondrial Proteins; Norepinephrine; Propranolol; Receptors, Adrenergic, beta; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Uncoupling Protein 1	2000

Article

Year

Thiazolidinediones inhibit the expression of beta3-adrenergic receptors at a transcriptional level.

Diabetes, 2000, Volume: 49, Issue:12

Topics: 3T3 Cells; Adrenergic beta-Agonists; Animals; Carrier Proteins; Cell Line; Chromans; Dioxoles; Drug Combinations; Half-Life; Ion Channels; Membrane Proteins; Mice; Mitochondrial Proteins; Norepinephrine; Propranolol; Receptors, Adrenergic, beta; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Uncoupling Protein 1

2000